2022-09-27 | Adobe Inc. ADBE | director | 1,200 0.0003% | $280.56 | $336,672 | +33.34% | ||
2019-10-25 | Eli Lilly and Company LLY | President & CEO | 9,230 0.001% | $108.38 | $1M | +34.48% | ||
2018-12-20 | Adobe Inc. ADBE | director | 150 <0.0001% | $216.58 | $32,487 | +26.8% | ||
2018-09-24 | Adobe Inc. ADBE | director | 150 <0.0001% | $261.43 | $39,215 | +1.44% | ||
2016-02-03 | Sale | Eli Lilly and Company LLY | President & CEO | 2,460 0.0002% | $76.73 | $188,756 | +1.2% | |
2016-02-01 | Sale | Eli Lilly and Company LLY | President & CEO | 3,273 0.0003% | $78.36 | $256,472 | -1.97% | |
2015-02-04 | Sale | Eli Lilly and Company LLY | President & CEO | 3,147 0.0003% | $69.99 | $220,259 | +18.71% | |
2015-02-02 | Sale | Eli Lilly and Company LLY | President & CEO | 4,769 0.0004% | $71.51 | $341,031 | +16.28% | |
2014-02-03 | Sale | Eli Lilly and Company LLY | SVP and Pres, Lilly Bio-Meds | 3,086 – | $0 | $0 | +21.37% | |
2013-02-08 | Sale | Eli Lilly and Company LLY | President & CEO | 3,000 0.0003% | $53.91 | $161,730 | +0.39% |